LERIMAZOLINE HYDROCHLORIDE
UNII PG85ABA8RC

Substance Identification & Data

This profile provides standardized clinical and technical data for Lerimazoline Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PG85ABA8RC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54707-83-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PG85ABA8RC

CAS Registry Number

54707-83-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LERIMAZOLINE HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H18N2.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PPDOMMDYAGCCGF-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C218009

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3016907

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(=NCCN1)Cc2c(cc(cc2C)C)C.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lerimazoline Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.